Litcius/Paper detail

Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection

Júlia Leão Batista Simões, Julia Beatrice de Araújo, Margarete Dulce Bagatini

2021Molecular Neurobiology13 citationsDOIOpen Access PDF

Topics & Concepts

Purinergic receptorMedicineNeuroinflammationCholinergicImmunologyMultiple sclerosisInflammationNeurologyImmune systemCytokineCoronavirusCytokine stormReceptorDiseaseInternal medicineCoronavirus disease 2019 (COVID-19)PsychiatryInfectious disease (medical specialty)Vagus Nerve Stimulation ResearchLong-Term Effects of COVID-19Nicotinic Acetylcholine Receptors Study
Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection | Litcius